BAT expects the U.S. to return to revenue and profit growth, driven by strengthening delivery in the combustibles category and the performance of its Velo Plus product. Facing regulatory and ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Across numerous industries, the customer experience (CX) is considered more important than ever. In fact, 96% of the CX ...

Alexandria Real Estate offers an unusually high 7.5% yield, at multi-decade low valuations. Click to read why ARE is rated ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

For most businesses, a major competitor shutting their doors would be welcome. But for pharmacists, taking on new clients can ...

Financing co-led by new investor BRM Group and existing investor Pontifax. Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatm ...

The UK gable top caps market grows with demand for lightweight, recyclable, tamper-evident, and compostable closures in dairy ...

In the first quarter of the year, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) widened its net loss by 39 percent to $92 ...

Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative “leapfrog” that could ...

Inovio Pharmaceuticals Inc. closed 82.97% below its 52-week high of $12.33, which the company reached on July 26th.